Second webinar of the series, From research and innovation to development: how to plan and execute translational projects in life sciences. This webinar will focus on the process involved with the release of new medical devices.
First webinar of the series, From research and innovation to development: how to plan and execute translational projects in life sciences, From bench to bedside focuses on the process of creating new medicines. Matthias Versele, Executive Director Drug Discovery from Cistim, Belgium, presents CD3-Cistim’s strategy for the evaluation and execution of drug development projects.
This EPO study gives insights into trends in innovation in water-related technologies aimed at both the provision of and protection from water.
With Laura Spinardi, Head of Technology Transfer Office, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, we discussed the challenges of managing data in digital clinical research: not just the privacy/personal data issues, but also data management and data sharing within collaborative research projects, using data for machine learning and training, and the ease or difficulty of transferring data in licensing and spin out opportunities.
Michiel Hulsbergen is CEO and founder of DialogueTrainer. In this edition of the Digital Innovation SIG World Lunch, Michiel shared the challenges he has faced setting up and running the company. As a spin-out from the Utrecht University, how did he navigate the issues of IP, funding and commercial development?
Biotechnology and genetics research have been the subject of extensive investment by both the public and private sectors, with the resulting products and processes making a significant and increasing contribution to human health and health care.
In this webinar recording, Anja Zimmerman, discusses how knowledge and technology transfer can happen in numerous ways, from publication of research results to collaborations between scientist, between research organisations, between academia and industry or by creating companies.
Biotechnology and genetics research have been the subject of extensive investment by both the public and private sectors, with the resulting products and processes making a significant and increasing contribution to human health and health care.
This document presents the guidelines for entering into research agreements with private companies, which have been adopted by the Danish teaching hospitals.
Join our newsletter and get the latest news